Psychedelics and Brain Networks

Update: 2025-09-23

Description

In this episode, we explore how psychedelics like psilocybin disrupt the brain's default mode network, creating windows of neuroplasticity that correlate with mystical experiences and therapeutic breakthroughs in treatment-resistant depression, anxiety, and addiction.

Faculty: Franklin King, M.D.
Host: Richard Seeber, M.D.

Comments

In Channel

Beyond Monotherapy: Mixed Episode Management

2025-11-0211:40

Old Drug, New Perspectives: Disulfiram's and Addiction Medicine

2025-10-2808:58

Quetiapine vs. Lithium in Mixed Bipolar States

2025-10-2313:52

Psychedelic-Assisted Therapy: Redefining Treatment

2025-10-1817:19

Lurasidone's Therapeutic Window: Is Less More?

2025-10-1313:50

Beyond Black Box Warnings: Choosing Antipsychotics in Dementia

2025-10-0811:30

SSRIs and Psychedelics: Drug Interactions

2025-10-0311:14

Standard vs. High Doses: Rethinking Bipolar Maintenance Treatment

2025-09-2814:06

Psychedelics and Brain Networks

2025-09-2314:11

LAIs vs Oral Antipsychotics: Mortality Data and Clinical Impact

2025-09-1816:33

The Science Behind Psychedelic Therapy

2025-09-1315:55

Which Antidepressant Causes the Most Weight Gain?

2025-09-0812:11

Lisdexamfetamine for Binge Eating Disorder

2025-09-0312:14

Beyond Weight Loss: GLP-1 Agonists and Alcohol Use Disorder

2025-08-2911:27

Antidepressants vs. Anticonvulsants for Binge Eating

2025-08-2411:26

Lithium Levels: Finding the Right Therapeutic Target

2025-08-1911:19

Antidepressants Beyond Depression: Applications in Bulimia Nervosa

2025-08-1409:28

Metformin and Antipsychotic-Induced Weight Gain: An Evidence-Based Solution

2025-08-0912:10

Monthly Injections, Long-Term Recovery: Naltrexone for OUD

2025-08-0408:17

Antipsychotics and Aspiration Risk

2025-07-3012:03

00:00

Psychedelics and Brain Networks

#box-pro-ellipsis-176221782972981{-webkit-line-clamp:2;}Psychedelics and Brain Networks

Psychedelics and Brain Networks

Psychedelics and Brain Networks